History

Since our establishment in 2011, Asclepius Meditec has dedicated itself to two core missions: device R D and medical research. For over 14 years, our commitment to innovation has never wavered. We have continuously invested in research and development, resulting in a robust portfolio of intellectual property and groundbreaking clinical studies.

To date, our efforts have yielded over 300 foundational research studies, 32 human clinical trials (16 single-center and 16 multi-center), and 97 medical papers published in collaboration with China's top 100 hospitals. Notably, 82 of these publications are SCI-indexed. Our commitment to innovation is further demonstrated by our extensive patent portfolio, which includes 458 patents, with the majority being invention patents.